357263-43-5

Basic information

• Product Name: 5-chloro-7-methyl-1H-pyrrolo[3,2-b]pyridine
• Synonyms: 5-chloro-7-methyl-1H-pyrrolo[3,2-b]pyridine;5-CHLORO-7-METHYL-4-AZAINDOLE;1H-Pyrrolo[3,2-b]pyridine, 5-chloro-7-Methyl-;1H-PYRROLO[3,2-b]PYRIDIN, 5-CHLORO-7-METHYL-
• CAS NO: 357263-43-5
• Molecular Formula: C8H7ClN2
• Molecular Weight: 166.61
• EINECS: 604-604-1
• Mol File: 357263-43-5.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 5-chloro-7-methyl-1H-pyrrolo[3,2-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-chloro-7-methyl-1H-pyrrolo[3,2-b]pyridine(357263-43-5)
• EPA Substance Registry System: 5-chloro-7-methyl-1H-pyrrolo[3,2-b]pyridine(357263-43-5)

Safety Data

• Hazardous Substances Data: 357263-43-5(Hazardous Substances Data)

Usage

General Description

5-chloro-7-methyl-1H-pyrrolo[3,2-b]pyridine, also known as CMP, is a chemical compound with a molecular formula C8H7ClN2. It is a heterocyclic aromatic compound with a pyrrolopyridine core structure. CMP is commonly used as a building block for the synthesis of pharmaceutical compounds, agrochemicals, and materials science applications. It has also been studied for its potential biological activities, including as an inhibitor of protein kinases and in the development of new drug candidates. Its unique chemical structure and potential for diverse applications make CMP an important compound in the field of organic chemistry and drug discovery.

InChI:InChI=1S/C8H7ClN2/c1-5-4-7(9)11-6-2-3-10-8(5)6/h2-4,10H,1H3

Upstream product

• 23056-33-9 2-chloro-4-methyl-5-nitro-pyridine 
• 1826-67-1 vinyl magnesium bromide 

Relevant articles and documents

PESTICIDALLY ACTIVE PYRIDYL- AND PYRIMIDYL- SUBSTITUTED THIAZOLE AND THIADIAZOLE DERIVATIVES

Compounds of formula (I), wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts and all stereoisomers and tautomeric forms of the compounds of formula (I) can be used as agrochemical active ingredients and can be prepared in a manner known per se.

KINASE INHIBITORS AND THEIR USE AS PHARMACEUTICAL AGENTS

Described herein are compounds that are inhibitors of one or more protein kinases. Also described are pharmaceutical compositions and medicaments that include the compounds described herein. Also described herein are methods of using such protein kinase inhibitors, alone and in combination with other compounds, for conditions or diseases mediated or dependent upon protein kinases

Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives

This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.